2013-05-03 18:21:02 -
The DSM Annual General Meeting of Shareholders on 3 May 2013 passed a resolution
to declare a dividend for 2012 of €1.50 per ordinary share of €1.50 par value.
An interim dividend of €0.48 per ordinary share having been paid on 30 August
2012, the final dividend for 2012 will amount to €1.02 per ordinary share. With
the passing of the resolution by the AGM, and in line with DSM's policy to
provide a stable and preferably rising dividend, 2012 marks the third
consecutive year DSM's dividend has been increased.
This final dividend of €1.02 will be paid out in cash or in the form of ordinary
shares at the option of the shareholder. Dividend in cash will be paid after
deduction of 15% Dutch dividend withholding tax. The
ex-dividend date on NYSE
Euronext will be 7 May 2013 and the record date will be 9 May 2013.
Shareholders have from 10 May until 24 May 2013 (3.00 pm CET) to indicate their
choice. On 27 May 2013 after the close of trading on NYSE Euronext the number of
dividend rights of ordinary shares entitling the holder to one ordinary share
will be determined.
This exchange ratio will be based on the volume weighted average price of all
ordinary shares in DSM traded at NYSE Euronext on 20 May 2013 up to and
including 24 May 2013. The value of the stock dividend will be virtually equal
to the value of the cash dividend. The ordinary shares that constitute the stock
dividend are entitled to any dividend for the financial year 2013 and to the
dividends for subsequent financial years. Stock dividend rights will not be
traded on NYSE Euronext.
The following timetable applies:
7 May 2013:
9 May 2013:
10 May 2013 - 24 May 2013(3.00 pm CET): Period in which shareholders can
indicate their choice
27 May 2013 (COB):
Announcement of the
29 May 2013:
shares or cash payment
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM's
23,500 employees deliver annual net sales of around €9 billion. The company is
listed on NYSE Euronext.
More information can be found at www.dsm.com.
Or find us on:
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Dave Huizing
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE